Dyne.Org Foundation

Dyne.Org Foundation company information, Employees & Contact Information

Since 1999 we run a non-profit and planetary effort lead by an international network of hackers dedicated to development of reliable software products. We support broad access to technology, recycling and freedom of expression by developing socially responsible tools, applications and community platforms. Dyne.org is active as an European research organisation, it is a think/do tank engaged both in socio-political analysis and development of technical solutions. We have decades of expertise adopting, developing and customising technologies for blockchain protocols, audio/video production, independent communication, private storage of information, autonomous p2p networking, hardware recycling, crypto currencies and trust management. We don't design with profit in mind: we look for financial and logistical support by ethical companies, institutions and donors sharing our visions for the betterment of society. We have a clear and transparent plan for redistributing wealth across our network, to activate and sustain on the longer term physical nodes in development and to develop and maintain more long-term software projects.

Company Details

Employees
16
Founded
-
Address
Haparandadam 7-A1, Amsterdam,noord-Holland 1013ak,netherlands
Email
in****@****yne.org
Industry
Think Tanks
NAICS
Research and Development in the Social Sciences and Humanities
Website
dyne.org
HQ
Amsterdam, Noord-Holland
Looking for a particular Dyne.Org Foundation employee's phone or email?

Dyne.org Foundation Questions

News

Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition - BioSpace

Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition BioSpace

Dyne: Accelerated Approval Established Endpoint Sets Stage For DM1 Data In Mid-2026 - Seeking Alpha

Dyne: Accelerated Approval Established Endpoint Sets Stage For DM1 Data In Mid-2026 Seeking Alpha

Dyne Therapeutics Appoints Brian Posner to its Board of Directors - GlobeNewswire

Dyne Therapeutics Appoints Brian Posner to its Board of Directors GlobeNewswire

DYNE-251 for DMD granted FDA breakthrough therapy designation - Muscular Dystrophy News

DYNE-251 for DMD granted FDA breakthrough therapy designation Muscular Dystrophy News

Dyne's stock dips as accelerated approval plans for dystrophy drug get delayed - FirstWord Pharma

Dyne's stock dips as accelerated approval plans for dystrophy drug get delayed FirstWord Pharma

Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital - Yahoo Finance

Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital Yahoo Finance

Sarepta shakes up C-suite amid org overhaul—Chutes & Ladders - Fierce Biotech

Sarepta shakes up C-suite amid org overhaul—Chutes & Ladders Fierce Biotech

Dyne Therapeutics' Valuation Leaves No Room For Error (NASDAQ:DYN) - Seeking Alpha

Dyne Therapeutics' Valuation Leaves No Room For Error (NASDAQ:DYN) Seeking Alpha

FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models | Communications Medicine - Nature

FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models | Communications Medicine Nature

Dyne Therapeutics to Present at Upcoming Investor Conferences - GlobeNewswire

Dyne Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire

Dyne Therapeutics Receives FDA Breakthrough Therapy Designation for DM1 Drug DYNE-101 - Yahoo Finance

Dyne Therapeutics Receives FDA Breakthrough Therapy Designation for DM1 Drug DYNE-101 Yahoo Finance

Safety Questions Loom in Duchenne as Dyne, Wave and Others Plan FDA Filings - BioSpace

Safety Questions Loom in Duchenne as Dyne, Wave and Others Plan FDA Filings BioSpace

EC grants orphan drug designation to Dyne Therapeutics’ DMD therapy - Pharmaceutical Technology

EC grants orphan drug designation to Dyne Therapeutics’ DMD therapy Pharmaceutical Technology

Dyne’s DMD trial advances patient mobility and dystrophin expression - Clinical Trials Arena

Dyne’s DMD trial advances patient mobility and dystrophin expression Clinical Trials Arena

DYNE-251 Increases Dystrophin Level Expression in Phase 1/2 DELIVER Trial of Duchenne - NeurologyLive

DYNE-251 Increases Dystrophin Level Expression in Phase 1/2 DELIVER Trial of Duchenne NeurologyLive

Dyne Therapeutics Announces FDA Breakthrough Therapy - GlobeNewswire

Dyne Therapeutics Announces FDA Breakthrough Therapy GlobeNewswire

Dyne Therapeutics: Emergence As A Superior DM1/DMD Player Warrants Rating Upgrade (DYN) - Seeking Alpha

Dyne Therapeutics: Emergence As A Superior DM1/DMD Player Warrants Rating Upgrade (DYN) Seeking Alpha

JPM25 Day 3: AbbVie, Gilead, GSK and Dyne - BioSpace

JPM25 Day 3: AbbVie, Gilead, GSK and Dyne BioSpace

Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments - GlobeNewswire

Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments GlobeNewswire

Exploring Dyne Therapeutics (DYN) Valuation After Recent Share Price Rebound - Yahoo Finance

Exploring Dyne Therapeutics (DYN) Valuation After Recent Share Price Rebound Yahoo Finance

Dyne Therapeutics (DYN) Is Up 17.0% After Positive One-Year ACHIEVE Trial Data for Z-Basivarsen – Has The Bull Case Changed? - Yahoo Finance

Dyne Therapeutics (DYN) Is Up 17.0% After Positive One-Year ACHIEVE Trial Data for Z-Basivarsen – Has The Bull Case Changed? Yahoo Finance

Dyne Reports Positive Phase 1/2 Data for Duchenne Agent DYNE-251 - NeurologyLive

Dyne Reports Positive Phase 1/2 Data for Duchenne Agent DYNE-251 NeurologyLive

Dyne Therapeutics Announces Proposed Public Offering of Common Stock - Yahoo Finance

Dyne Therapeutics Announces Proposed Public Offering of Common Stock Yahoo Finance

Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy - Yahoo Finance

Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy Yahoo Finance

Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer - GlobeNewswire

Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer GlobeNewswire

RBC Capital Maintains a Buy Rating on Dyne Therapeutics (DYN) With a $25 PT - Yahoo Finance

RBC Capital Maintains a Buy Rating on Dyne Therapeutics (DYN) With a $25 PT Yahoo Finance

Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire

Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights GlobeNewswire

Duro Dyne Corporation | Asbestos, Mesothelioma - Mesothelioma.net

Duro Dyne Corporation | Asbestos, Mesothelioma Mesothelioma.net

Dyne adjusts regulatory timeline for DYNE-101 after FDA feedback - The Pharma Letter

Dyne adjusts regulatory timeline for DYNE-101 after FDA feedback The Pharma Letter

MDA 2025: DYNE-101 improves finger function in DM1 clinical trial - Muscular Dystrophy News

MDA 2025: DYNE-101 improves finger function in DM1 clinical trial Muscular Dystrophy News

Dyne shares jump on trial data for muscle disease drugs - BioPharma Dive

Dyne shares jump on trial data for muscle disease drugs BioPharma Dive

Dyne pivots on primary endpoint, delays filing for DM1 drug - Endpoints News

Dyne pivots on primary endpoint, delays filing for DM1 drug Endpoints News

3 execs resign as Dyne posts mixed data for DMD candidate - Fierce Biotech

3 execs resign as Dyne posts mixed data for DMD candidate Fierce Biotech

Van Dyne, WI, Firefighter Succumbs Following Injury at Station - firehouse.com

Van Dyne, WI, Firefighter Succumbs Following Injury at Station firehouse.com

Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) - GlobeNewswire

Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) GlobeNewswire

Dyne Therapeutics - Massachusetts Biotechnology Council

Dyne Therapeutics Massachusetts Biotechnology Council

Drug Developer Dyne Therapeutics Weigh Options After Takeover Interest - Bloomberg.com

Drug Developer Dyne Therapeutics Weigh Options After Takeover Interest Bloomberg.com

Neuromuscular Disease Pioneer Dyne Therapeutics Secures Massive $200M Stock Offering: Key Details Revealed - Stock Titan

Neuromuscular Disease Pioneer Dyne Therapeutics Secures Massive $200M Stock Offering: Key Details Revealed Stock Titan

Alexxander Van Dyne Obituary (1961 - 2023) - Los Angeles, CA - Los Angeles Times - Legacy obituary

Alexxander Van Dyne Obituary (1961 - 2023) - Los Angeles, CA - Los Angeles Times Legacy obituary

Darwin O'Neil Van Dyne Obituary (2025) - Clovis, CA - Clovis Funeral Chapel & Cremation Services - Legacy obituary

Darwin O'Neil Van Dyne Obituary (2025) - Clovis, CA - Clovis Funeral Chapel & Cremation Services Legacy obituary

Anne Van Dyne Obituary (2024) - Springfield, OR - Springfield Memorial Gardens & Funeral Home - Legacy obituary

Anne Van Dyne Obituary (2024) - Springfield, OR - Springfield Memorial Gardens & Funeral Home Legacy obituary

Dyne Therapeutics to Present New Preclinical Data in - GlobeNewswire

Dyne Therapeutics to Present New Preclinical Data in GlobeNewswire

Catalytic Heaters at Oil and Gas Sites May be a Significant yet Overlooked Seasonal Source of Methane Emissions - ACS Publications

Catalytic Heaters at Oil and Gas Sites May be a Significant yet Overlooked Seasonal Source of Methane Emissions ACS Publications

Clinical Phenotype in Individuals With Birk-Landau-Perez Syndrome Associated With Biallelic SLC30A9 Pathogenic Variants - Neurology® Journals

Clinical Phenotype in Individuals With Birk-Landau-Perez Syndrome Associated With Biallelic SLC30A9 Pathogenic Variants Neurology® Journals

Neuromuscular Disease Pioneer Dyne Therapeutics to Present Latest Updates at Major Healthcare Forums - Stock Titan

Neuromuscular Disease Pioneer Dyne Therapeutics to Present Latest Updates at Major Healthcare Forums Stock Titan

Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months - GlobeNewswire

Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months GlobeNewswire

Dyne Therapeutics Stock Drops After ‘Surprise’ Pivot In Primary Endpoint For Muscle Drug Trial - Stocktwits

Dyne Therapeutics Stock Drops After ‘Surprise’ Pivot In Primary Endpoint For Muscle Drug Trial Stocktwits

Dyne Therapeutics Hits Major Milestone: DMD Trial Fully Enrolled, Two FDA Submissions Coming in 2026 - Stock Titan

Dyne Therapeutics Hits Major Milestone: DMD Trial Fully Enrolled, Two FDA Submissions Coming in 2026 Stock Titan

Piezo1 expression in neutrophils regulates shear-induced NETosis - Nature

Piezo1 expression in neutrophils regulates shear-induced NETosis Nature

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for D - GlobeNewswire

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for D GlobeNewswire

Anne Dyne Obituary (2025) - Northamptonshire Telegraph - Legacy obituary

Anne Dyne Obituary (2025) - Northamptonshire Telegraph Legacy obituary

Analysis of flow-induced transcriptional response and cell alignment of different sources of endothelial cells used in vascular tissue engineering - Nature

Analysis of flow-induced transcriptional response and cell alignment of different sources of endothelial cells used in vascular tissue engineering Nature

TrpA1 is a shear stress mechanosensing channel regulating intestinal stem cell proliferation in Drosophila - Science | AAAS

TrpA1 is a shear stress mechanosensing channel regulating intestinal stem cell proliferation in Drosophila Science | AAAS

Dyne: Accelerated Approval DYNE-101 Might Be Possible With Surrogate Biomarker (DYN) - Seeking Alpha

Dyne: Accelerated Approval DYNE-101 Might Be Possible With Surrogate Biomarker (DYN) Seeking Alpha

Hope van Dyne’s Mission is Central to the Plot of Ant-Man and the Wasp - Motion Picture Association

Hope van Dyne’s Mission is Central to the Plot of Ant-Man and the Wasp Motion Picture Association

Abusive Supervision, Leader-Member Exchange, and Creativity: A Multilevel Examination - Frontiers

Abusive Supervision, Leader-Member Exchange, and Creativity: A Multilevel Examination Frontiers

Automated screening of sickle cells using a smartphone-based microscope and deep learning | npj Digital Medicine - Nature

Automated screening of sickle cells using a smartphone-based microscope and deep learning | npj Digital Medicine Nature

Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015 - Centers for Disease Control and Prevention | CDC (.gov)

Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015 Centers for Disease Control and Prevention | CDC (.gov)

Designers to Watch in 2023: Dyne - nationaljeweler.com

Designers to Watch in 2023: Dyne nationaljeweler.com

Nancy Van Dyne Fleming - Legacy obituary

Nancy Van Dyne Fleming Legacy obituary

NSI Industries Acquires Duro Dyne Corp. - ACHR News

NSI Industries Acquires Duro Dyne Corp. ACHR News

‘Ant-Man: Quantumania’ Trailer Finally Explains Where Janet Van Dyne Got That Sick Outfit - The Mary Sue

‘Ant-Man: Quantumania’ Trailer Finally Explains Where Janet Van Dyne Got That Sick Outfit The Mary Sue

With Dyne, Christopher Bevans Aims to Make Clothing as Smart as Your Phone - fashionista.com

With Dyne, Christopher Bevans Aims to Make Clothing as Smart as Your Phone fashionista.com

Establishing Baseline Cervical Cancer Screening Coverage — India, 2015–2016 - Centers for Disease Control and Prevention | CDC (.gov)

Establishing Baseline Cervical Cancer Screening Coverage — India, 2015–2016 Centers for Disease Control and Prevention | CDC (.gov)

Dyne raises $233M in 19th Mass. IPO this year - The Business Journals

Dyne raises $233M in 19th Mass. IPO this year The Business Journals

Samuel Van Dyne Obituary (2003) - Kansas City, MO - Kansas City Star - Legacy obituary

Samuel Van Dyne Obituary (2003) - Kansas City, MO - Kansas City Star Legacy obituary

Obituary: Donald F. Van Dyne - SummitDaily.com

Obituary: Donald F. Van Dyne SummitDaily.com

The Wasp is a Marvel Legacy Character and Finally her Time has Come - Motion Picture Association

The Wasp is a Marvel Legacy Character and Finally her Time has Come Motion Picture Association

Harry Van Dyne - ESPN

Harry Van Dyne ESPN

Wasp (Janet Van Dyne) | Characters - marvel.com

Wasp (Janet Van Dyne) | Characters marvel.com

Michael Dyne, 70, Writer of Dramas for TV (Published 1989) - The New York Times

Michael Dyne, 70, Writer of Dramas for TV (Published 1989) The New York Times

Top Dyne.Org Foundation Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant